InsidersTradesSigma
Track the DXN LIMITED share price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares are quoted on AU AU, under the oversight of ASX. Market capitalisation: €76.3m. The latest transaction was reported on 9 July 2026 (Change in Substantial Holding). Among the most active insiders: Notice of change of interests of substantial holder. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
DXN LIMITED is a company listed on the Australian Securities Exchange, specializing in health and wellness products. It focuses on the distribution of mushroom-based products and other dietary supplements.